SUSPENSION LETTER - MAILED
mailed
on 24 Jul 2024
Last Applicant/ Owned by
1050-1040 Georgia St W
Vancouver, BC
CA
V6E4H1
Serial Number
98157366 filed on 30th Aug 2023
Registration Number
N/A
Filing Basis
No Filing Basis
Disclaimer
NO DATA
MELIUS
Medical, scientific and veterinary research, namely clinical trials; conducting interventional clinical studies; pharmaceutical drug development services for others; pharmaceutical product evaluation; pharmaceutical research and development; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; providing scientific research information in the fi Read More
Classification Information
Class [042]
Computer & Software Services & Scientific Services
Medical, scientific and veterinary research, namely clinical trials; conducting interventional clinical studies; pharmaceutical drug development services for others; pharmaceutical product evaluation; pharmaceutical research and development; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; providing scientific research information in the fields of pharmaceuticals; medical, scientific and veterinary research in the fields of clinical trials and post-market trials; research on the subject of pharmaceuticals; scientific research for the development of CRISPR-based platforms and products in the field of genetic engineering
First Use Date in General
N/A
First Use Date in Commerce
N/A
Class [039]
Transportation & Storage Services
Delivery of prescription drugs
First Use Date in General
N/A
First Use Date in Commerce
N/A
Class [035]
Advertising, Business & Retail Services
Business administration of medication reimbursement programs and services; administration and management of research grants; business administration of prescription drug programs designed to process medical insurance claims for products used by consumers; business administration of prescription drug programs designed to process medical insurance claims for services used by consumers; business administrative services for medical referrals; advertising services for promoting public awareness of the benefits of general health and wellness; advertising services for promoting public awareness of the benefits of nutrition; advertising services to promote public awareness of medical conditions; advertising services to promote public awareness on health issues; advertising services to promote public awareness on healthcare issues; analysis of market research data and statistics; providing business assistance to others in preparing and filing applications for new drugs with governmental regulatory bodies; business administration of a program to provide access to medicines at low or no cost to underserved populations; business administration of a program to provide discounts on prescription medicines; business administration of medication reimbursement programs and services; business mediation of agreements and contracts for the purchase and sale of health preparations for medical purposes; collection and compilation of medical report information into databases; compilation of medical reports; compilation of statistical data into databases in the field of scientific or medical research; consulting services in the field of administrative processing of health insurance claims for health insurers, administrators and payers; consulting services in the field of medical product approval for commercial purposes; consulting services in the field of patient relationship management for healthcare providers; market analysis; market analysis and research; market assessment consultancy; market assessment services; preparation of market reports; conducting market studies; market research consultancy; market research services; market research studies; market studies; medical billing; medical billing support services; medical cost management; medical records coding services for others for purposes of reimbursement from insurance; business administrative services for medical referrals; on-line retail store services featuring dietary supplements; on-line retail store services featuring dietetic preparations; on-line wholesale store services featuring dietary supplements; on-line wholesale store services featuring dietetic preparations; online and retail store services featuring of prescription drugs
First Use Date in General
N/A
First Use Date in Commerce
N/A
Class [005]
Pharmaceutical Products
Medicines for the treatment of gastrointestinal diseases; pharmaceutical preparations and substances for the treatment of gastrointestinal diseases; pharmaceutical preparations for human use in the field of metabolic disorders, namely, diabetes, obesity, hyperlipidemia, insulin resistance, metabolic syndrome; pharmaceutical preparations for the treatment of gastrointestinal disorders; pharmaceutical preparations for the treatment of inflammation and inflammatory diseases, namely, inflammatory bowel diseases, inflammatory connective tissue diseases, inflammatory pelvic diseases; pharmaceutical preparations for the treatment of mental health disorders; pharmaceutical preparations for the prevention and treatment of metabolic disorders, namely, diabetes, obesity, hyperlipidemia, insulin resistance, metabolic syndrome; pharmaceutical preparations for the treatment of digestive diseases and disorders, namely, crohn's disease, irritable bowel syndrome; probiotic bacterial formulations for medical purposes; probiotic preparations for medical purposes to help maintain a natural balance of flora in the digestive system
First Use Date in General
N/A
First Use Date in Commerce
N/A
Mark Details
Serial Number
No 98157366
Mark Type
No Service Mark
Attorney Docket Number
No 1177-00-T03
44D Filed
Yes
44D Current
Yes
44E filed
No
44E Current
No
66A Filed
No
66A Current
No
Current Basis
No
No Basis
No
Legal History
| Status Date | Action Taken |
|---|---|
| 24th Jul 2024 | SUSPENSION LETTER WRITTEN |
| 24th Jul 2024 | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED |
| 24th Jul 2024 | LETTER OF SUSPENSION E-MAILED |
| 18th Jul 2024 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| 17th Jul 2024 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| 17th Jul 2024 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| 20th Apr 2024 | NON-FINAL ACTION E-MAILED |
| 20th Apr 2024 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| 20th Apr 2024 | NON-FINAL ACTION WRITTEN |
| 19th Apr 2024 | ASSIGNED TO EXAMINER |